| PERIOD ENDING | 31-Oct-08 | 31-Oct-07 | | Total Revenue | 292 |
-
| | Cost of Revenue | 221 |
-
| | | Gross Profit | 71 |
-
| | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 6,611 | 27 | | Non Recurring |
-
|
-
| | Others | 90 |
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (6,631) | (27) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (880) |
-
| | Earnings Before Interest And Taxes | (7,510) | (27) | | Interest Expense | 65 | 0 | | Income Before Tax | (7,575) | (27) | | Income Tax Expense |
-
|
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (7,575) | (27) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (7,575) | (27) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($7,575) | ($27) |
|
0.83% Nasdaq 
0.001 (1.67%) 
Income Statement
